Printer Friendly
The Free Library
4,719,285 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Abbott clarifies proper dosage of oral solution.


Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois.  disseminated a Dear Healthcare Provider Letter throughout the world to physicians and pharmacists that prescribe/distribute Kaletra Oral Solution, FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 stated in a release Aug. 14.

The letter informed healthcare professionals of an accidental overdose that occurred with a pediatric patient pediatric patient Child, see there  taking Kaletra Oral Solution. The infant received a significantly large dose of Kaletra and subsequently died.

Healthcare professionals should pay special attention to accurate calculation of the dose of Kaletra, transcription of the medication order, dispensing information and dosing instructions to minimize the risk for medication errors medication error Malpractice An error in the type of medication administered or dosage. See Adverse effect, Error. .

Read the complete MedWatch 2007 safety summary including a link to the Manufacturer's Dear Healthcare Provider Letter and Prescribing Information regarding this issue at: http://www.fda.gov/medwatch/safety/2007/safety07.htm#Kaletra.
COPYRIGHT 2007 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Warnings/Recalls
Publication:Adverse Event Reporting News
Article Type:Brief article
Date:Aug 27, 2007
Words:124
Previous Article:Health Canada reports PML after Rituxan use.(Warnings/Recalls)
Next Article:Dietary supplements recalled.(Warnings/Recalls)(Brief article)
Topics:



Related Articles
Abbott hosts FDA again; hit for bacterial validation.
New observations follow partial fixes at Abbott Labs.(Brief Article)
The Patentability of Medicinal Inventions Related to Personalised Medicine in Japan.
Federal Circuit Affirms Abbott's Biaxin Injunction.
PMPRB Issues Notice Of Hearing: Abbott Laboratories, Limited And The Medicine ZEMPLAR.(Patented Medicine Prices Review Board )
Anti-fungal medication recalled due to glass fragments.(MedWatch)(Brief article)
Grassley presses EPO makers on safety, pricing and marketing.(Drug/biologics safety)(Erythropoietin)
Boston Scientific to settle suits over flawed defibrillators.(Drug Safety)(Brief article)
Single lot of morphine recalled due to double dosage.(Warnings/recalls)(Brief article)
BRIEFS.(BUSINESS)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles